BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 15653156)

  • 1. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
    Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
    J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
    Tan EC; Lin R; Wang CH
    J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
    Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
    Taluja A; Bae YH
    Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.
    Seo SA; Khang G; Rhee JM; Kim J; Lee HB
    J Microencapsul; 2003; 20(5):569-79. PubMed ID: 12909542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
    Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
    J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement.
    Schnieders J; Gbureck U; Thull R; Kissel T
    Biomaterials; 2006 Aug; 27(23):4239-49. PubMed ID: 16620958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
    Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
    J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.